Page 11 - Jay Bradner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

After seven years as President of NIBR and a member of the ECN, Dr. Bradner will pursue a next chapter of scientific contribution and leadership outside of Novartis Building on NIBR foundation, Dr. Marshall to shape next era of biomedical innovation and continue Novartis leadership in R&D Novartis today announced that James (Jay) E. Bradner, M.D., will step down from the Executive Committee of Novartis (ECN), effective October 31st after seven years leading research at Novartis. Fiona H.

BioPharma

ZURICH (Reuters) - Novartis appointed Merck executive Fiona Marshall as president of the Novartis Institutes for Biomedical Research to replace Jay Br...

01.09.2022 - After seven years as President of NIBR and a member of the ECN, Dr. Bradner will pursue a next chapter of scientific contribution and leadership outside of NovartisBuilding on NIBR foundation, Dr. Marshall to shape next era of biomedical innovation ... Seite 1

Otherwise they might end up a niche treatment for a small number of patients in rich countries | Briefing